المؤلفون: Elke Lipka (14240511), Aaron M. Chadderdon (14240514), Cheryl C. Harteg (14240517), Matthew K. Doherty (14240520), Eric S. Simon (14240523), John M. Domagala (2521279), Dawn M. Reyna (14240526), Kim M. Hutchings (6599891), Xinmin Gan (2004670), Andrew D. White (1842340), Caroll B. Hartline (14240529), Emma A. Harden (3364058), Kathy A. Keith (2497426), Mark N. Prichard (252944), Scott H. James (14240532), Rhonda D. Cardin (3385631), David I. Bernstein (8099324), Jacqueline F. Spencer (14240535), Ann E. Tollefson (13802965), William S. M. Wold (14240538), Karoly Toth (785339)

مصطلحات موضوعية: Biophysics, Biochemistry, Medicine, Microbiology, Cell Biology, Pharmacology, Biotechnology, Ecology, Immunology, Mental Health, Infectious Diseases, Virology, Chemical Sciences not elsewhere classified, target tissue levels, rapid intracellular conversion, promising lead candidate, overall clinical utility, optimized metabolic stability, increased cellular permeability, exhibit histological signs, excellent cellular uptake, excellent aqueous solubility, compounds maintained plasma, added capping groups, spectrum antiviral therapeutic, novel lead candidate, spectrum antiviral compound, alkyl chain length, 50 , hamsters following oral

Relation: https://figshare.com/articles/journal_contribution/NPP-669_a_Novel_Broad-Spectrum_Antiviral_Therapeutic_with_Excellent_Cellular_Uptake_Antiviral_Potency_Oral_Bioavailability_Preclinical_Efficacy_and_a_Promising_Safety_Margin/21701754

الاتاحة: https://doi.org/10.1021/acs.molpharmaceut.2c00668.s001